首页 | 本学科首页   官方微博 | 高级检索  
     


Potential biomarkers of an exaggerated response to endotoxemia
Authors:R. S. Kasthuri  M. Wroblewski  B. Jilma  N. S. Key  G. L. Nelsestuen
Affiliation:1. Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA;2. Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA;3. Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria;4. Department of Pharmaceutics, University of Florida, Gainesville, Florida, USA;5. Division of Hematology and Oncology, University of North Carolina, Chapel Hill, North Carolina, USA
Abstract:Serial plasma protein analysis was used to study the acute plasma proteome response to endotoxemia (presence of toxic bacterial products called endotoxins in the blood stream). Plasma samples from healthy volunteers before and multiple time points up to 24 h following administration of low-dose endotoxin were evaluated. Plasma protein profiles were obtained by rapid extraction of whole plasma followed by analysis with matrix-assisted laser desorption ionisation-time of flight mass spectrometry. The profiles were unique to each individual and stable over the time of the experiment. Administration of low-dose endotoxin caused profound change in six of 18 individuals. At 8 h many proteins showed quantitative oxidation, in addition to the appearance of new components and disappearance of common baseline components. An exceptionally intense new component at 4154 mass units was identified as the activation peptide of C1 esterase inhibitor. While recovery of baseline protein structure was nearly complete by 24 h, serum amyloid A, an acute-phase reactant, was still increasing and minor profile changes persisted. Clinical features did not distinguish these extreme responders from others, suggesting that plasma proteome changes offered unique insights into and potential biomarkers of subclinical events following endotoxin exposure.
Keywords:Biomarkers  acute-phase reactants  complement  human  lipopolysaccharide
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号